Gf Fund Management Co. Ltd. Rhythm Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,290 shares of RYTM stock, worth $74,407. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,290Holding current value
$74,407% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
214Shares Held
64.4MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$389 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$379 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$351 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$351 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$212 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.21B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...